Figure 4From: A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutantsComparison of EC 50 values of selected analogs against an expanded set of mutants. Values for mutants not shown in Figure 3 are included in Additional file 1: Table S1.Back to article page